Single Nucleotide Polymorphism rs11136000 of CLU Gene (Clusterin, ApoJ) and the Risk of Late-Onset Alzheimer’s Disease in a Central European Population

被引:0
|
作者
Vladimir J. Balcar
Tomáš Zeman
Vladimír Janout
Jana Janoutová
Jan Lochman
Omar Šerý
机构
[1] The University of Sydney,Bosch Institute and Discipline of Anatomy and Histology, School of Medical Sciences, Faculty of Medicine and Health
[2] Academy of Sciences of the Czech Republic,Laboratory of Neurobiology and Pathological Physiology, Institute of Animal Physiology and Genetics
[3] Masaryk University,Laboratory of Neurobiology and Molecular Psychiatry, Department of Biochemistry, Faculty of Science
[4] University of Ostrava,Department of Epidemiology and Public Health, Faculty of Medicine
[5] Palacký University Olomouc,Present address: Faculty of Health Sciences
来源
Neurochemical Research | 2021年 / 46卷
关键词
Clusterin; Late-onset Alzheimer’s disease; Mild cognitive impairment; Single nucleotide polymorphism; Neurodegeneration; Neuroprotection; Genetic risk;
D O I
暂无
中图分类号
学科分类号
摘要
Clusterin (CLU; also known as apolipoprotein J, ApoJ) is a protein of inconstant structure known to be involved in diverse processes inside and outside of brain cells. CLU can act as a protein chaperon or protein solubilizer, lipid transporter as well as redox sensor and be anti- or proapoptotic, depending on context. Primary structure of CLU is encoded by CLU gene which contains single nucleotide polymorphisms (SNP’s) associated with the risk of late-onset Alzheimer’s disease (LOAD). Studying a sample of Czech population and using the case-control association approach we identified C allele of the SNP rs11136000 as conferring a reduced risk of LOAD, more so in females than in males. Additionally, data from two smaller subsets of the population sample suggested a possible association of rs11136000 with diabetes mellitus. In a parallel study, we found no association between rs11136000 and mild cognitive impairment (MCI). Our findings on rs11136000 and LOAD contradict those of some previous studies done elsewhere. We discuss the multiple roles of CLU in a broad range of molecular mechanisms that may contribute to the variability of genetic studies of CLU in various ethnic groups. The above discordance notwithstanding, our conclusions support the association of rs1113600 with the risk of LOAD.
引用
收藏
页码:411 / 422
页数:11
相关论文
共 50 条
  • [31] Association of Single-Nucleotide Polymorphism in ANK1 with Late-Onset Alzheimer’s Disease in Han Chinese
    Song Chi
    Jing-Hui Song
    Meng-Shan Tan
    Wei Zhang
    Zi-Xuan Wang
    Teng Jiang
    Lan Tan
    Jin-Tai Yu
    Molecular Neurobiology, 2016, 53 : 6476 - 6481
  • [32] Association of Single-Nucleotide Polymorphism in ANK1 with Late-Onset Alzheimer's Disease in Han Chinese
    Chi, Song
    Song, Jing-Hui
    Tan, Meng-Shan
    Zhang, Wei
    Wang, Zi-Xuan
    Jiang, Teng
    Tan, Lan
    Yu, Jin-Tai
    MOLECULAR NEUROBIOLOGY, 2016, 53 (09) : 6476 - 6481
  • [33] SORL1 gene polymorphism association with late-onset Alzheimer's disease
    Feng, Xialu
    Hou, Deren
    Deng, Yanyao
    Li, Wei
    Tian, Mi
    Yu, Zhuling
    NEUROSCIENCE LETTERS, 2015, 584 : 382 - 389
  • [34] Presenilin-1 gene intronic polymorphism in late-onset Alzheimer's disease
    Dursun, E
    Gezen-Ak, D
    Eker, E
    Ertan, T
    Engin, F
    Hanagasi, H
    Gurvit, H
    Emre, M
    Yilmazer, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S511 - S511
  • [35] Presenilin-1 Gene Intronic Polymorphism and Late-onset Alzheimer's Disease
    Dursun, Erdinc
    Gezen-Ak, Duygu
    Eker, Engin
    Ertan, Turan
    Engin, Funda
    Hanagasi, Hasmet
    Guervit, Hakan
    Emre, Murat
    Yilmazer, Selma
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2008, 21 (04) : 268 - 273
  • [36] APOE -: 491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease
    Casadei, VM
    Ferri, C
    Veglia, F
    Gavazzi, A
    Salani, G
    Cattaneo, M
    Sorbi, S
    Annoni, G
    Licastro, F
    Mariani, C
    Franceschi, M
    Grimaldi, LME
    NEUROLOGY, 1999, 53 (08) : 1888 - 1889
  • [37] Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population
    Koivisto, AM
    Helisalmi, S
    Pihlajamäki, J
    Moilanen, L
    Kuusisto, J
    Laakso, M
    Hiltunen, M
    Keijo, V
    Hänninen, T
    Helkala, EL
    Kervinen, K
    Kesäniemi, YA
    Soininen, H
    JOURNAL OF NEUROGENETICS, 2005, 19 (3-4) : 155 - 161
  • [38] The association of a cystatin C gene polymorphism with late-onset Alzheimer's disease and vascular dementia
    Lin, C
    Wang, ST
    Wu, CW
    Chuo, LJ
    Kuo, YM
    CHINESE JOURNAL OF PHYSIOLOGY, 2003, 46 (03): : 111 - 115
  • [39] Interleukin 1α gene C(-889)T polymorphism in late-onset Alzheimer's disease
    Ak, DG
    Dursun, E
    Ertan, T
    Bilgic, B
    Gurvit, H
    Emre, M
    Eker, E
    Engin, F
    Yilmazer, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S504 - S504
  • [40] Monoamine oxidase A polymorphism in Brazilian patients - Risk factor for late-onset Alzheimer's disease?
    Nishimura, AL
    Guindalini, C
    Oliveira, JRM
    Nitrini, R
    Bahia, VS
    de Brito-Marques, PR
    Otto, PA
    Zatz, M
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2005, 27 (02) : 213 - 217